, Tracking Stock Market Picks
Enter Symbol:
Rating: JUNO
Outperform $73

Juno Therapeutics Inc. (NASDAQ: JUNO) rated to Outperform with price target $73 by FBR Capital

Tuesday,  Aug 18, 2015  8:25 AM ET by Lynn Gilbert

FBR Capital rated Juno
Therapeutics Inc. (NASDAQ: JUNO) to Outperform with price target $73.

FBR Capital uses a highly disciplined analysis focused on intrinsic value, which we developed to critically examine the capital structure of the companies we cover, as well as their competitive positions and the growth opportunities within their industries. We apply this discipline – which helps us assess how effectively a company’s managers deploy the capital entrusted to them – not only in our published research but also when making investing and underwriting judgments.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy